Of note, positive correlations between poor prognosis and PEA3 overexpression have been identified in cancers of several tissue sites including carcinomas of the breast, ovary, stomach and CRC [39], [44], [46], [47]. The gene discussed is ETV4; the disease is colorectal carcinoma.